Global Information Inc. would like to present a new market research report, "Diabetes Care Devices Market to 2018 - Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management" by GBI Research.
The global market for diabetes care devices is forecast to reach $25.3 billion by 2018, with a Compound Annual Growth Rate (CAGR) of 5.2% from 2011 to 2018. Glucose monitoring devices will be the largest category in the market, with a value of $13.3 billion by 2018. The insulin delivery devices market was valued at $8.1 billion in 2011, and is forecast to grow at a CAGR of 5.9% to reach revenues of $12 billion in 2018.
The market is primarily expected to be driven during the forecast period by the large patient pool suffering from diabetes and the rapid uptake of innovative, minimally or non-invasive products. Examples include the C8 MediSensors Optical Glucose Monitor, NBM-200G, Easy Check Breath Glucose and EyeSense Blood Glucose Measurement Device, which utilize a patients sweat, exhaled breath or a fluorescent eye signal to measure blood glucose levels. Integrated Continuous Glucose Monitoring (CGM) systems will also contribute to the growth of the glucose monitoring devices market.
Compelling clinical needs, expanding research activities and applications to develop non-invasive therapies will accelerate technological innovations in diabetes care devices. Moreover, increasing awareness, improving diagnosis and treatment rates and a growing demand for safer, more effective, more accurate and cost-effective therapies for diabetes will lead to increased adoption rates for diabetes care devices.
F. Hoffmann-La Roche is the Dominant Player in the Global Diabetes Care Devices Market
In 2011, Roche, with a market share of 15.2%, was the leader in the global diabetes care devices market.
Roches Accu-Chek line of blood glucose monitoring devices and insulin delivery devices has driven the growth of the company. Roche was followed by LifeScan and Medtronic, which had market shares of 14.2% and 7.5% respectively. The OneTouch brand of blood glucose monitoring devices by Lifescan, and Medtronics MiniMed line of insulin pumps, witnessed strong growth in 2011. Novo Nordisk, Sanofi and Eli Lilly, which specialize in insulin delivery devices, had similar market shares of 7.5%, 7.0% and 6.9% respectively. The launch of products that are innovative and technologically advanced will strengthen the market position of these major players. The market share among the top players in the diabetes care devices market is expected to be dynamic in the future, as Bayer HealthCare AG, with a market share of 6.9% of the total diabetes care devices market in 2011, is seeking to divest its blood glucose meters business (Bayer via Reuters, 2012).
The Global Diabetes Care Devices Pipeline is Dominated by Glucose Monitoring Devices
The current diabetes care devices market scenario demands substantial output from the Research and Development (R&D) departments of medical device companies. The demand for innovative, non-invasive and user-friendly diabetes care devices is on the rise. The current diabetes care devices pipeline includes a total of 187 pipeline products, of which the glucose monitoring devices category has the highest number of products.
The glucose monitoring devices category, with 113 pipeline products alone, accounts for 60% of the total number of pipeline products, followed by the insulin delivery devices category with 46 pipeline products. The artificial pancreas category has 13 products in the pipeline, and accounts for 7% of the total number of pipeline products. The increasing demand for non-invasive devices is leading to the development of new technologies such as measurement of blood glucose levels using occlusion spectroscopy, infrared spectrometry and Raman spectroscopy, and insulin delivery using Intellispring technology and MEMS (Micro Electro Mechanical Systems) chip technology. With the application of new technologies, these devices are expected to be more accurate, more efficacious and more user-friendly compared to the currently marketed products.